📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Phase I Study Protocol for Ex Vivo Lentiviral Gene Therapy for the Inherited Skin Disease, Netherton Syndrome (2013)

First Author: Di W

Attributed to: BRIC: Packaging cell lines for inherently manufacturable viral vectors funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1089/humc.2013.195

PubMed Identifier: 24329107

Publication URI: http://europepmc.org/abstract/MED/24329107

Type: Journal Article/Review

Parent Publication: Human Gene Therapy Clinical Development

Issue: 4

ISSN: 2324-8637